Thomas Sweeney Heard

Array ( [id] => 8324380 [patent_doc_number] => 20120196794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'Combinations of Hepatitis C Virus Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/195317 [patent_app_country] => US [patent_app_date] => 2011-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6255 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13195317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9538295 [patent_doc_number] => 20140162942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'INHIBITION OF CYP3A DRUG METABOLISM' [patent_app_type] => utility [patent_app_number] => 13/812221 [patent_app_country] => US [patent_app_date] => 2011-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18286 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733876 [patent_doc_number] => 20120016105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'PURIFICATION OF PEPTIDE CONJUGATES BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY' [patent_app_type] => utility [patent_app_number] => 13/186726 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 58102 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016105.pdf [firstpage_image] =>[orig_patent_app_number] => 13186726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762294 [patent_doc_number] => 08846617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Inflammation inhibiting compounds' [patent_app_type] => utility [patent_app_number] => 13/184518 [patent_app_country] => US [patent_app_date] => 2011-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 10252 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13184518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10191877 [patent_doc_number] => 09220771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Peptide for use in the treatment of breast cancer and/or bone metastases' [patent_app_type] => utility [patent_app_number] => 13/810593 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 31 [patent_no_of_words] => 69396 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511396 [patent_doc_number] => 20110257106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Polymer Stabilized Neuropeptides' [patent_app_type] => utility [patent_app_number] => 13/170760 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8663 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257106.pdf [firstpage_image] =>[orig_patent_app_number] => 13170760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884745 [patent_doc_number] => 20130157929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'GLUCAGON ANALOGUES' [patent_app_type] => utility [patent_app_number] => 13/704299 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12760 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7479277 [patent_doc_number] => 20110247988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'APPARATUS AND METHOD FOR SEPARATION OF LIQUID PHASES OF DIFFERENT DENSITY AND FOR FLUOROUS PHASE ORGANIC SYNTHESES' [patent_app_type] => utility [patent_app_number] => 13/168131 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8308 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20110247988.pdf [firstpage_image] =>[orig_patent_app_number] => 13168131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574027 [patent_doc_number] => 20110269683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'RECEPTOR(SSTR2)-SELECTIVE SOMATOSTATIN ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/159020 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9349 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269683.pdf [firstpage_image] =>[orig_patent_app_number] => 13159020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160127 [patent_doc_number] => 20120101031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/154721 [patent_app_country] => US [patent_app_date] => 2011-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59012 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101031.pdf [firstpage_image] =>[orig_patent_app_number] => 13154721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854118 [patent_doc_number] => 20130143793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'PEPTIDE CONJUGATES OF GLP-1 RECEPTOR AGONISTS AND GASTRIN AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/642349 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23191 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561287 [patent_doc_number] => 20110275120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Fusion Proteins With Cleavable Spacers and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/093734 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21938 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275120.pdf [firstpage_image] =>[orig_patent_app_number] => 13093734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167844 [patent_doc_number] => 20110196012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'DEUTERATED MACROCYCLIC INHIBITORS OF VIRAL NS3 PROTEASE' [patent_app_type] => utility [patent_app_number] => 13/092801 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9786 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20110196012.pdf [firstpage_image] =>[orig_patent_app_number] => 13092801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112925 [patent_doc_number] => 20110190195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'MULTI-COMPONENT ANTIOXIDANT COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE FOR REDUCING OR PREVENTING OXIDATIVE STRESS' [patent_app_type] => utility [patent_app_number] => 13/086429 [patent_app_country] => US [patent_app_date] => 2011-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13122 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190195.pdf [firstpage_image] =>[orig_patent_app_number] => 13086429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8637062 [patent_doc_number] => 20130028865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'Combination of a Macrocyclic Inhibitor of HCV, A Non-Nucleoside and a Nucleoside' [patent_app_type] => utility [patent_app_number] => 13/640657 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5659 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186508 [patent_doc_number] => 20120115796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Novel Spacer Moiety for Poly(ehtylene Glycol) Modified Peptide Based Compounds' [patent_app_type] => utility [patent_app_number] => 13/079615 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 14354 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115796.pdf [firstpage_image] =>[orig_patent_app_number] => 13079615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8607123 [patent_doc_number] => 20130012434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/636244 [patent_app_country] => US [patent_app_date] => 2011-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62031 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187699 [patent_doc_number] => 20110171175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'INHIBITORS OF SERINE PROTEASES' [patent_app_type] => utility [patent_app_number] => 13/051557 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20312 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171175.pdf [firstpage_image] =>[orig_patent_app_number] => 13051557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163773 [patent_doc_number] => 20110160430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'FLUORINE-LABELED COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/032099 [patent_app_country] => US [patent_app_date] => 2011-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7669 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160430.pdf [firstpage_image] =>[orig_patent_app_number] => 13032099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026550 [patent_doc_number] => 08536132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Lymphatic zip codes in tumors and pre-malignant lesions' [patent_app_type] => utility [patent_app_number] => 13/024445 [patent_app_country] => US [patent_app_date] => 2011-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 31714 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13024445 [rel_patent_id] =>[rel_patent_doc_number] =>)